QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · IEX Real-Time Price · USD
39.64
-0.05 (-0.13%)
Apr 26, 2024, 4:00 PM EDT - Market closed
QuidelOrtho Revenue
In the year 2023, QuidelOrtho had annual revenue of $3.00B, a decrease of -8.21%. Revenue in the quarter ending December 31, 2023 was $742.60M, a -14.30% decrease year-over-year.
Revenue (ttm)
$3.00B
Revenue Growth
-8.21%
P/S Ratio
0.88
Revenue / Employee
$422,225
Employees
7,100
Market Cap
2.65B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
Dec 31, 2021 | 1.70B | 36.90M | 2.22% |
Dec 31, 2020 | 1.66B | 1.13B | 210.66% |
Dec 31, 2019 | 534.89M | 12.61M | 2.41% |
Dec 31, 2018 | 522.29M | 244.54M | 88.05% |
Dec 31, 2017 | 277.74M | 86.14M | 44.96% |
Dec 31, 2016 | 191.60M | -4.53M | -2.31% |
Dec 31, 2015 | 196.13M | 11.97M | 6.50% |
Dec 31, 2014 | 184.16M | 6.83M | 3.85% |
Dec 31, 2013 | 177.33M | 21.58M | 13.86% |
Dec 31, 2012 | 155.74M | -2.86M | -1.80% |
Dec 31, 2011 | 158.60M | 45.26M | 39.94% |
Dec 31, 2010 | 113.34M | -50.94M | -31.01% |
Dec 31, 2009 | 164.28M | 36.15M | 28.21% |
Dec 31, 2008 | 128.13M | 10.07M | 8.53% |
Dec 31, 2007 | 118.07M | 12.05M | 11.37% |
Dec 31, 2006 | 106.02M | 13.72M | 14.86% |
Dec 31, 2005 | 92.30M | 13.61M | 17.29% |
Dec 31, 2004 | 78.69M | -13.77M | -14.89% |
Dec 31, 2003 | 92.46M | 19.19M | 26.19% |
Dec 31, 2002 | 73.27M | 2.29M | 3.23% |
Dec 31, 2001 | 70.98M | 5.49M | 8.37% |
Dec 31, 2000 | 65.50M | 8.98M | 15.88% |
Dec 31, 1999 | 56.52M | 7.04M | 14.23% |
Mar 31, 1998 | 49.48M | 4.76M | 10.64% |
Mar 31, 1997 | 44.72M | 9.67M | 27.58% |
Mar 31, 1996 | 35.05M | 3.52M | 11.15% |
Mar 31, 1995 | 31.54M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neogen | 929.24M |
ACADIA Pharmaceuticals | 726.44M |
Certara | 354.34M |
MorphoSys AG | 264.75M |
Arrowhead Pharmaceuticals | 181.74M |
PROCEPT BioRobotics | 136.19M |
Arcellx | 110.32M |
Merus | 43.95M |
QDEL News
- 7 hours ago - Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL - Accesswire
- 11 hours ago - DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm - Accesswire
- 1 day ago - QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 - QDEL - Accesswire
- 1 day ago - QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL - Accesswire
- 1 day ago - DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm - Accesswire
- 1 day ago - Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Accesswire
- 1 day ago - Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact Levi & Korsinsky - Accesswire
- 1 day ago - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrtho Lawsuit - QDEL - Accesswire